Journal of Multiple Sclerosis and Neuroimmunology

Search

Page Path

HOME
Search

Case Report

Severe Neutropenia Following Rituximab Treatment in Patients with Multiple Sclerosis: Ki Hoon Kim, Su-Hyun Kim, Jae-Won Hyun, Ho Jin Kim; J Mult Scler Neuroimmunol. 2024;15(1):31-34. Published online June 30, 2024; DOI: https://doi.org/10.59578/jmsni.2024.15.1.31; Full text PubReader ePub PDF

Volume 15, No. 1

Journal of Multiple
Sclerosis and
Neuroimmunology

Print ISSN: 2733-8290
Online ISSN: 2951-2972

MOST VIEWED MOST CITED

6,008	Understanding MRI Features of Multiple Sclerosis: Based on the 2017 McDonald Criteria
2,661	Rituximab Treatment for Neuroimmunologic Disorders
2,354	National Consensus Guidance for the Diagnosis and Management of Adult Patients with Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease
2,324	Multiple Sclerosis in Korea: A Hospital-Based, Multicenter, Epidemiological Study
2,215	Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease: A Review

Cited By
2

Multiple Sclerosis in Korea: A Hospital-Based, Multicenter, Epidemiological Study

Editorial Office: Department of Neurology, Chung-Ang University Hospital, Chung-Ang University College of Medicine 102, Heukseok-ro, Dongjak-gu, Seoul 06973, Korea
Tel: +82-2-6299-3153 E-mail: icandr@cau.ac.kr

Copyright © 2024 by Korean Society of Neuroimmunology.